Ixazomib-induced Sweet's syndrome

Int J Hematol. 2020 Feb;111(2):161-162. doi: 10.1007/s12185-019-02797-6. Epub 2019 Dec 11.

Authors

Takuya Suyama¹, Syusaku Ito², Atsushi Shinagawa³

Affiliations

¹ Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi, Ibaraki, 317-0077, Japan. takuya.suyama.yt@hitachi.com.
² Dermatology Division, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
³ Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi, Ibaraki, 317-0077, Japan.

PMID: 31828594
DOI: 10.1007/s12185-019-02797-6

No abstract available

Keywords: Ixazomib; Multiple myeloma; Sweet’s syndrome.

Publication types

Letter

MeSH terms

Boron Compounds / adverse effects*
Glycine / adverse effects
Glycine / analogs & derivatives*
Humans
Sweet Syndrome / chemically induced*

Substances

Boron Compounds
ixazomib
Glycine